Grace Therapeutics, Inc
Price
FilingsNewest: 8-K, Shareholder voteSep 18 →InsidersNo open-market buys or sales.→HoldersCerity Partners 5.2%Eversept Partners 4.7%Bank OF America Corp /de/ 3.0%→Financing →PeersClosest companies: CING, IXHL, RLMD→
From the filings
Figures
- Net income
- −$20.2Mlast 12 months
- Operating cash flow
- −$10.3Mlast 12 months
- Cash and equivalents
- $13.8Mat the last balance sheet
- Shares outstanding
- 16.3M shareson issue